ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1580

Abnormal High Density Lipoproteins in Synovial Fluid from Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Arthritis

Christina Charles-Schoeman1, Yuen Yin Lee2, Ani Shahbazian1, David Meriwether3, Peter Kim2 and Srinivasa T. Reddy4, 1Medicine-Rheumatology, University of California Los Angeles, Los Angeles, CA, 2Medicine- Rheumatology, University of California Los Angeles, Los Angeles, CA, 3Medicine- Cardiology, University of California Los Angeles, Los Angeles, CA, 4Medicine-Cardiology, University of California Los Angeles, Los Angeles, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cholesterol, rheumatoid arthritis (RA) and synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Session Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   High levels of rheumatoid arthritis (RA) disease activity have been
associated with abnormal function of circulating high density lipoproteins
(HDL) and increased cardiovascular risk.  Oxidative modifications to the HDL
particle by enzymes such as myeloperoxidase (MPO) occur in atherosclerotic
plaques of non-RA patients and adversely affect HDL function.  In the current
work, we evaluated the oxidant environment and anti-oxidant function of HDL in
synovial fluid (SF) from RA patients compared to patients with non-inflammatory
arthritis (NIA).

 

Methods: HDL
was isolated from synovial fluid of 10 RA patients and 11 NIA patients by
dextran bead precipitation.  HDL’s anti-oxidant function was measured by a cell
free assay as described previously (A&R 2009; 60(10): 2870-9). MPO
and paraoxonase 1 (PON1) activity (using both paraoxonase and arylesterase
assays), were measured in SF by previously published assays with minor
modifications (
ARD 2012 Jul;71(7):1157-62, A&R 2012; 64(6):1828-37).  Oxidation products of arachidonic acid and
linoleic acid including 5 hydroxyeicosatetraenoic acid (HETE), 12-HETE,
15-HETE, 9-hydroxyoctadecadienoic acid (HODE) and 13-HODE were measured in
synovial fluid by mass spectrometry as described previously with minor
modifications (
Drug Metab Lett. 2010; 4(3): 139-48). Total and HDL
cholesterol (HDL-C) levels in SF were determined by standard methods.

 

Results: HDL
in SF from RA patients had significantly worse anti-inflammatory, anti-oxidant
function as measured by a higher mean HDL inflammatory index (HII) compared to
SF HDL from patients with NIA (see table).  RA SF had significantly higher MPO
activity and higher levels of 15-HETE which were most strongly correlated with
SF macrophage cell counts (r values= 0.7 and 0.6 respectively, p values
<0.05) and showed trends for correlations with the HII (r = 0.5 and 0.3
respectively, p values =0.2).  Higher levels of total cholesterol, HDL-C, and
PON1 activity were noted in RA SF compared to NIA SF (see table).

 

Conclusion: HDL
is increased in RA SF and is pro-inflammatory and pro-oxidant compared to HDL
from NIA SF. These findings suggest a potential mechanism by which circulating
HDL in active RA patients lose their protective capacity by exposure to the
pro-oxidant joint milieu, linking high RA disease activity to abnormal HDL
function, and potentially increased CV risk.

 

 

Group

HII

Age (yrs)

F    (%)

SF total

WBC Ct.

SF Neut.

Ct.

SF Mac.

Ct.

MPO activity

 (ng/ml)

HDL-C (mg/dL)

TC (mg/dL)

PON activity

 (U/ml)

Aryl

activity

(U/ml)

5HETE (ng/ml SF)

12HETE (ng/ml SF)

15HETE(ng/ml SF)

9HODE (ng/ml SF)

13HODE  (ng/ml SF)

RA SF

2.1 ± 1.9*

55±  13

60

15409 ±  6153*

11840±7000*

2074±1490*

74 ± 48*

18 ±

10

59 ±

17*

412 ± 150*

93± 43*

0.44± 0.33

0.12± 0.07

0.37± 0.07*

1.31± 1.70

4.15± 4.20

NIA SF

0.5 ± 0.1

69 ±  19

55

617 ±  496

120 ± 177

247 ± 135

0.9 ± 0.6

12 ±

 7

26 ±

 17

122± 129

27± 10

0.57± 0.68

0.12± 0.05

0.26± 0.11

0.63± 0.36

2.02± 1.20

HII=HDL
Inflammatory Index; F = Female; WBC = White blood cell; Ct = count; Neut =
neutrophil; Mac = macrophage; TC = total cholesterol; Aryl = Arylesterase. *p
value < 0.05 compared to NIA.

 


Disclosure: C. Charles-Schoeman, None; Y. Y. Lee, None; A. Shahbazian, None; D. Meriwether, None; P. Kim, None; S. T. Reddy, None.

To cite this abstract in AMA style:

Charles-Schoeman C, Lee YY, Shahbazian A, Meriwether D, Kim P, Reddy ST. Abnormal High Density Lipoproteins in Synovial Fluid from Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/abnormal-high-density-lipoproteins-in-synovial-fluid-from-patients-with-rheumatoid-arthritis-compared-to-patients-with-non-inflammatory-arthritis/. Accessed May 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abnormal-high-density-lipoproteins-in-synovial-fluid-from-patients-with-rheumatoid-arthritis-compared-to-patients-with-non-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences